Latest Sales Pipeline News

Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.

AnteoTech has locked in an underwriting deal to guarantee up to $7.5 million from the exercise of listed options, potentially raising as much as $10 million before costs.

ReadCloud Limited’s 1H26 results reveal robust growth in school-focused businesses, with cash receipts up 22% and operating cash flow rising 10%, positioning the company to outperform its FY26 earnings guidance.

Mainfreight reported a 2.8% revenue increase to NZ$5.38 billion for FY26, but profit before tax declined 8.5% to NZ$350.9 million, weighed down by higher overheads and regional challenges. The company declared a steady final dividend and outlined ongoing network expansion plans.

UOA Development Bhd’s Q1 2026 results reveal a decline in revenue and profit compared to last year, despite a solid RM130.7 million in new property sales and a substantial unbilled sales pipeline.

Energy One Limited reveals solid sales momentum and strategic AI integration under new CEO Ben Tranier, despite slight ARR timing delays and ongoing market complexity.

AnteoTech has secured independent validation of its Ultranode™ 95 silicon anode in commercial-format battery cells, demonstrating over 40% higher energy density and strong cycle life, advancing its push into the growing drone battery market.

Operator XR, a subsidiary of xReality Group, has landed its first European deal supplying a VR tactical training system to the Swedish Armed Forces, marking its debut in NATO markets.

US Masters Residential Property Group (URF) sold 40 properties for US$48.59 million in Q1 2026, cutting its portfolio to 121 assets valued at US$123.21 million. The Group targets a full exit by year-end amid stable market conditions despite geopolitical and local political challenges.

TechnologyOne has delivered a record half-year profit and annual recurring revenue, driven by its AI-powered SaaS+ platform and strong sector wins, while reaffirming its FY26 growth guidance.

Lumos Diagnostics advances US commercial rollout of FebriDx with positive reimbursement data and expanded urgent care adoption ahead of the 2027/28 flu season.

Spenda Limited has sold its Ledger platform to APG Pay for $1.8 million, cutting $2.7 million in annual costs and streamlining operations to concentrate on its core revenue-generating products.